Teva Pharmaceutical Industries LTD
SEC CIK 818686 · TEVA · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lieberman Gerald M | Director | filed 2018 - 2026 |
| Barer SOL J | Director | filed 2018 - 2026 |
| Mignone Roberto | Director | filed 2018 - 2026 |
| Crane Rosemary A | Director | filed 2018 - 2026 |
| Nisen Perry | Director | filed 2018 - 2026 |
| Zaks Tal Zvi | Director | filed 2021 - 2026 |
| Elstein Amir | Director | filed 2018 - 2026 |
| Satchi-Fainaro Ronit | Director | filed 2018 - 2026 |
| Lichtenstein Chen | Director | filed 2024 - 2026 |
| Vergis Janet S. | Director | filed 2020 - 2025 |
| Shalev Varda | Director | filed 2023 - 2025 |
| Schultz Kare | Director · President and CEO | filed 2018 - 2022 |
| Halfon Jean Michel | Director | filed 2018 - 2022 |
| Peres Nechemia Jacob | Director | filed 2018 - 2022 |
| Hussain Abbas | Director | filed 2020 - 2021 |
| Goldberg Murray A | Director | filed 2018 - 2019 |
| Suesskind Dan S | Director | filed 2018 - 2018 |
| Sulzberger Gabrielle | Director | filed 2018 - 2018 |
| Maor Galia | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shields Matthew | EVP, Global Operations | filed 2024 - 2026 |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | filed 2020 - 2026 |
| Francis Richard D | President and CEO | filed 2023 - 2026 |
| Lippman Evan | EVP, Business Development | filed 2025 - 2026 |
| Daniell Richard | Exec. VP, European Commercial | filed 2018 - 2026 |
| Weiss Amir | Chief Accounting Officer | filed 2021 - 2026 |
| Sabag Mark | See "Remarks" below | filed 2018 - 2026 |
| Fox Christine | EVP, U.S. Commercial | filed 2023 - 2026 |
| Hughes Eric A | See "Remarks" | filed 2022 - 2026 |
| Jover Placid | See "Remarks" | filed 2024 - 2026 |
| Savage Brian | Interim Chief Legal Officer | filed 2026 - 2026 |
| Mcavoy David R. | EVP, Chief Legal Officer | filed 2024 - 2025 |
| Grant Angus | EVP, Business Development | filed 2023 - 2024 |
| Conway Vikki L | See "Remarks" | filed 2023 - 2024 |
| Drape Eric | Executive VP Global Operations | filed 2019 - 2024 |
| Bergwerk Dov | Acting Chief Legal Officer | filed 2023 - 2024 |
| Stark David Matthew | Exec. VP Chief Legal Officer | filed 2018 - 2023 |
| Dethlefs Sven | EVP, North America Commercial | filed 2018 - 2023 |
| Shani Eli | EVP,Global Marketing&Portfolio | filed 2021 - 2023 |
| Inbar Galia | See "Remarks" | filed 2021 - 2023 |
| Fridriksdottir Hafrun | Executive VP, Global R&D | filed 2018 - 2022 |
| Weil Andrew | Chief Accounting Officer | filed 2021 - 2021 |
| Nazzi Gianfranco | EVP, International Markets | filed 2018 - 2021 |
| O'Grady Brendan P. | EVP, North America Commercial | filed 2018 - 2021 |
| Griffin Deborah A | Chief Accounting Officer | filed 2018 - 2020 |
| Mcclellan Michael James | EVP, Chief Financial Officer | filed 2018 - 2019 |
| de Notaristefani Carlo | Executive VP Global Operations | filed 2018 - 2019 |
| Codner Iris Beck | EVP Global Brand&Communication | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.